Wednesday, May 27, 2009

Aricept ODT


See also: Generic Aricept


Aricept ODT is a brand name of donepezil, approved by the FDA in the following formulation(s):


ARICEPT ODT (donepezil hydrochloride - tablet, orally disintegrating; oral)



  • Manufacturer: EISAI INC

    Approval date: October 18, 2004

    Strength(s): 10MG [RLD][AB], 5MG [AB]

Has a generic version of Aricept ODT been approved?


A generic version of Aricept ODT has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Aricept ODT and have been approved by the FDA:


donepezil hydrochloride tablet, orally disintegrating; oral



  • Manufacturer: BARR

    Approval date: November 26, 2010

    Strength(s): 10MG [AB], 5MG [AB]


  • Manufacturer: SANDOZ

    Approval date: May 10, 2011

    Strength(s): 10MG [AB], 5MG [AB]


  • Manufacturer: ZYDUS PHARMS USA INC

    Approval date: May 10, 2011

    Strength(s): 10MG [AB], 5MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Aricept ODT. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Rapidly disintegrable tablet containing polyvinyl alcohol
    Patent 7,727,548
    Issued: June 1, 2010
    Inventor(s): Morita; Yutaka & Yasui; Masanobu & Ohwaki; Takayuki & Tsushima; Yuki
    Assignee(s): Eisai R&D Management Co., Ltd.
    The present invention provides a quickly disintegrating tablet which has quick disintegrability and solubility in an oral cavity, and does not have uncomfortable tastes such as bitterness, has a small variation of a tablet physical property even in storage under a humidifying condition, and has substantially no change in a medicine content in the tablet and tablet appearance and which is superior in stability; and a manufacturing method of the tablet. That is, it provides: a quickly disintegrating tablet which is prepared by blending a medicine with a saccharide and polyvinyl alcohol, which has small variations of tablet weight, tablet hardness, tablet diameter and tablet thickness, and which is superior in medicine stability in the tablet; and a manufacturing method of the tablet.
    Patent expiration dates:

    • June 23, 2022
      ✓ 
      Patent use: ADMINISTRATION OF APPROVED PRODUCT FOR TREATMENT OF ALZHEIMER'S DISEASE
      ✓ 
      Drug product




  • Oral pharmaceutical preparations decreased in bitterness by masking
    Patent 7,727,552
    Issued: June 1, 2010
    Inventor(s): Ukai; Koji & Hrada; Tsutomu & Suzuki; Yasuyuki
    Assignee(s): Eisai R&D Management Co., Ltd.
    A composition of an oral medicine or an oral medicine which can prevent an unpleasant taste of the medicine is herein disclosed. It is granules, powders, syrups and the like which is prevented from an unpleasant taste, comprising a basic medicine having an unpleasant taste and an anionic polymer such as carrageenan.
    Patent expiration dates:

    • March 26, 2018
      ✓ 
      Drug product



See also...

  • Aricept ODT Orally Disintegrating Tablets Consumer Information (Wolters Kluwer)
  • Aricept ODT Consumer Information (Cerner Multum)
  • Donepezil Consumer Information (Wolters Kluwer)
  • Donepezil Orally Disintegrating Tablets Consumer Information (Wolters Kluwer)
  • Donepezil Consumer Information (Cerner Multum)
  • Donepezil Advanced Consumer Information (Micromedex)
  • Donepezil Hydrochloride AHFS DI Monographs (ASHP)

Apo-Tenoxicam




Apo-Tenoxicam may be available in the countries listed below.


Ingredient matches for Apo-Tenoxicam



Tenoxicam

Tenoxicam is reported as an ingredient of Apo-Tenoxicam in the following countries:


  • Canada

  • Vietnam

International Drug Name Search

Sunday, May 24, 2009

Vantas


Vantas is a brand name of histrelin, approved by the FDA in the following formulation(s):


VANTAS (histrelin acetate - implant; subcutaneous)



  • Manufacturer: ENDO PHARM

    Approval date: October 12, 2004

    Strength(s): 50MG [RLD]

Has a generic version of Vantas been approved?


No. There is currently no therapeutically equivalent version of Vantas available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Vantas. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Vantas.

See also...

  • Vantas Consumer Information (Drugs.com)
  • Vantas Implant Consumer Information (Wolters Kluwer)
  • Vantas implant Consumer Information (Cerner Multum)
  • Vantas Advanced Consumer Information (Micromedex)
  • Vantas AHFS DI Monographs (ASHP)
  • Supprelin-LA Consumer Information (Drugs.com)
  • Histrelin Implant Consumer Information (Wolters Kluwer)
  • Histrelin implant Consumer Information (Cerner Multum)
  • Histrelin Subcutaneous Advanced Consumer Information (Micromedex)
  • Histrelin acetate Subcutaneous Advanced Consumer Information (Micromedex)
  • Histrelin AHFS DI Monographs (ASHP)

Wednesday, May 20, 2009

Antobron




Antobron may be available in the countries listed below.


Ingredient matches for Antobron



Ambroxol

Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Antobron in the following countries:


  • Japan

International Drug Name Search

Tuesday, May 19, 2009

Retin-A


Retin-A is a brand name of tretinoin topical, approved by the FDA in the following formulation(s):


RETIN-A (tretinoin - cream; topical)



  • Manufacturer: VALEANT INTL

    Approved Prior to Jan 1, 1982

    Strength(s): 0.05% [RLD][AB1], 0.1% [RLD][AB]


  • Manufacturer: VALEANT INTL

    Approval date: September 16, 1988

    Strength(s): 0.025% [RLD][AB]

RETIN-A (tretinoin - gel; topical)



  • Manufacturer: VALEANT INTL

    Approved Prior to Jan 1, 1982

    Strength(s): 0.01% [RLD][AB], 0.025% [RLD][AB]

RETIN-A (tretinoin - solution; topical)



  • Manufacturer: VALEANT INTL

    Approved Prior to Jan 1, 1982

    Strength(s): 0.05% [RLD][AT]

Has a generic version of Retin-A been approved?


Yes. The following products are equivalent to Retin-A:


AVITA (tretinoin cream; topical)



  • Manufacturer: MYLAN BERTEK

    Approval date: January 14, 1997

    Strength(s): 0.025% [AB]

tretinoin cream; topical



  • Manufacturer: TRIAX PHARMS LLC

    Approval date: December 24, 1998

    Strength(s): 0.025% [AB], 0.05% [AB1], 0.1% [AB]

tretinoin gel; topical



  • Manufacturer: TRIAX PHARMS LLC

    Approval date: February 22, 2000

    Strength(s): 0.025% [AB]


  • Manufacturer: TRIAX PHARMS LLC

    Approval date: June 11, 2002

    Strength(s): 0.01% [AB]

tretinoin solution; topical



  • Manufacturer: WOCKHARDT

    Approval date: January 25, 1999

    Strength(s): 0.05% [AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Retin-A. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Retin-A.

See also...

  • Retin-A Cream Consumer Information (Wolters Kluwer)
  • Retin-A Gel Consumer Information (Wolters Kluwer)
  • Retin-A Liquid Consumer Information (Wolters Kluwer)
  • Retin-A Consumer Information (Cerner Multum)
  • Retin-A Topical Advanced Consumer Information (Micromedex)
  • Retin A Consumer Information (Drugs.com)
  • Tretinoin Cream Consumer Information (Wolters Kluwer)
  • Tretinoin Emollient Cream Consumer Information (Wolters Kluwer)
  • Tretinoin Gel Consumer Information (Wolters Kluwer)
  • Tretinoin Liquid Consumer Information (Wolters Kluwer)
  • Tretinoin topical Consumer Information (Cerner Multum)
  • Rejuva-A Topical Advanced Consumer Information (Micromedex)
  • Retin-A Micro Topical Advanced Consumer Information (Micromedex)
  • Vitamin A Acid Topical Advanced Consumer Information (Micromedex)
  • Tretinoin Topical Advanced Consumer Information (Micromedex)
  • Tretinoin topical AHFS DI Monographs (ASHP)

Saturday, May 16, 2009

Zanidion




Zanidion may be available in the countries listed below.


Ingredient matches for Zanidion



Codeine

Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Zanidion in the following countries:


  • Vietnam

Paracetamol

Paracetamol is reported as an ingredient of Zanidion in the following countries:


  • Vietnam

International Drug Name Search

Thursday, May 14, 2009

Microsona




Microsona may be available in the countries listed below.


Ingredient matches for Microsona



Hydrocortisone

Hydrocortisone is reported as an ingredient of Microsona in the following countries:


  • Argentina

  • Mexico

International Drug Name Search

Monday, May 11, 2009

Kalidren




Kalidren may be available in the countries listed below.


Ingredient matches for Kalidren



Diclofenac

Diclofenac potassium salt (a derivative of Diclofenac) is reported as an ingredient of Kalidren in the following countries:


  • Turkey

International Drug Name Search

divalproex sodium



dye-VAL-proe-ex SOE-dee-um


Oral route(Tablet, Enteric Coated;Tablet, Extended Release;Capsule, Delayed Release)

Hepatotoxicity (some cases fatal), usually occurring during the first 6 months of treatment, has been reported in patients receiving valproic acid and its derivatives. Children under the age of two years are at a considerably increased risk of developing fatal hepatotoxicity. Monitor patients closely, and perform liver function tests prior to therapy and at frequent intervals thereafter. Valproate can produce teratogenic effects such as neural tube defects (eg, spina bifida). Accordingly, the use of divalproex sodium in women of childbearing potential requires that the benefits of its use be weighed against the risk of injury to the fetus. Life-threatening pancreatitis has been reported in both children and adults receiving valproate. If pancreatitis is diagnosed, valproate should ordinarily be discontinued .



Commonly used brand name(s)

In the U.S.


  • Depakote

  • Depakote DR

  • Depakote ER

  • Depakote Sprinkles

In Canada


  • Alti-Valproic

Available Dosage Forms:


  • Tablet, Extended Release

  • Tablet, Enteric Coated

  • Tablet, Delayed Release

  • Capsule, Delayed Release

  • Syrup

Therapeutic Class: Anticonvulsant


Pharmacologic Class: Valproic Acid


Chemical Class: Valproic Acid


Uses For divalproex sodium


Divalproex sodium is used alone or together with other medicines to control certain types of seizures (convulsions) in the treatment of epilepsy. divalproex sodium is an anticonvulsant that works in the brain tissue to stop seizures.


Divalproex sodium is also used to treat the manic phase of bipolar disorder (manic-depressive illness), and helps prevent migraine headaches.


divalproex sodium is available only with your doctor's prescription.


Before Using divalproex sodium


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For divalproex sodium, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to divalproex sodium or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of divalproex sodium in children. However, safety and efficacy have not been established in children below 10 years of age. Because of divalproex sodium's toxicity, use in children below 2 years of age requires extreme caution.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of divalproex sodium in the elderly. However, elderly patients are more likely to have unwanted effects (e.g., tremors or unusual drowsiness), which may require an adjustment in the dose for patients receiving divalproex sodium.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersDStudies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy in a life threatening situation or a serious disease, may outweigh the potential risk.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking divalproex sodium, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using divalproex sodium with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Doripenem

  • Ertapenem

  • Imipenem

  • Ketorolac

  • Lamotrigine

  • Meropenem

  • Naproxen

  • Primidone

  • Vorinostat

  • Warfarin

Using divalproex sodium with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Acyclovir

  • Aspirin

  • Betamipron

  • Carbamazepine

  • Cholestyramine

  • Clomipramine

  • Erythromycin

  • Ethosuximide

  • Felbamate

  • Fosphenytoin

  • Ginkgo

  • Lopinavir

  • Lorazepam

  • Mefloquine

  • Nimodipine

  • Nortriptyline

  • Olanzapine

  • Oxcarbazepine

  • Panipenem

  • Phenobarbital

  • Phenytoin

  • Rifampin

  • Rifapentine

  • Risperidone

  • Ritonavir

  • Rufinamide

  • Topiramate

  • Zidovudine

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of divalproex sodium. Make sure you tell your doctor if you have any other medical problems, especially:


  • Brain disease, severe or

  • Congenital metabolism disorders (born with a disease that affects metabolism) or

  • Mental retardation with severe seizure disorders—Use with caution. May increase risk for more serious side effects.

  • Liver disease or

  • Urea cycle disorder (genetic disorder)—Should not be used in patients with these conditions.

  • Pancreatitis (inflammation of the pancreas) or

  • Thrombocytopenia (low platelet count)—May make these conditions worse.

Proper Use of divalproex sodium


Take divalproex sodium exactly as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered. To keep blood levels constant, take divalproex sodium at the same time each day and do not miss any doses.


divalproex sodium comes with a medication guide and patient information insert. Read and follow the instructions in the insert carefully. Ask your doctor if you have any questions.


You may take divalproex sodium with food to avoid stomach upset.


The sprinkle capsules may be opened and the contents may be sprinkled onto soft food such as applesauce or pudding. This mixture must be swallowed immediately without chewing and followed with a glass of water to ensure complete swallowing of the sprinkles.


Swallow the extended release tablet whole with a full glass of water. Do not split, crush, or chew it.


Dosing


The dose of divalproex sodium will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of divalproex sodium. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage forms (delayed-release tablets):
    • For mania:
      • Adults—At first, 750 milligrams (mg) once a day, usually divided in smaller doses. Your doctor may increase your dose as needed. However, the dose is usually not more than 60 milligrams (mg) per kilogram (kg) of body weight a day.

      • Children—Use and dose must be determined by your doctor.


    • For migraine:
      • Adults—At first, 250 milligrams (mg) two times a day. Your doctor may increase your dose as needed. However, the dose is usually not more than 1000 mg a day.

      • Children—Use and dose must be determined by your doctor.


    • For seizures:
      • Adults and children 10 years of age or older—Dose is based on body weight and must be determined by your doctor. At first, the usual dose is 10 to 15 milligrams (mg) per kilogram (kg) of body weight a day to start. Your doctor may increase your dose gradually every week by 5 to 10 mg per kg of body weight if needed. However, the dose is usually not more than 60 mg per kg of body weight a day. If the total dose a day is greater than 250 mg, it is usually divided into smaller doses and taken two or more times during the day.

      • Children below 10 years of age—Use and dose must be determined by your doctor.



  • For oral dosage forms (extended release tablets):
    • For mania:
      • Adults—Dose is based on body weight and must be determined by your doctor. At first, the usual dose is 25 milligrams (mg) per kilogram (kg) of body weight once a day to start. Your doctor may increase your dose if needed. However, the dose is usually not more than 60 mg per kg of body weight a day.

      • Children—Use and dose must be determined by your doctor.


    • For migraine:
      • Adults—At first, 500 milligrams (mg) once a day for 1 week. Your doctor may increase your dose as needed. However, the dose is usually not more than 1000 mg a day.

      • Children—Use and dose must be determined by your doctor.


    • For seizures:
      • Adults and children 10 years of age or older—Dose is based on body weight and must be determined by your doctor. At first, the usual dose is 10 to 15 milligrams (mg) per kilogram (kg) of body weight a day to start. Your doctor may increase your dose gradually every week by 5 to 10 mg per kg of body weight if needed. However, the dose is usually not more than 60 mg per kg of body weight a day.

      • Children below 10 years of age—Use and dose must be determined by your doctor.



  • For oral dosage form (sprinkle capsules):
    • For seizures:
      • Adults and children 10 years of age or older—Dose is based on body weight and must be determined by your doctor. At first, the usual dose is 10 to 15 milligrams (mg) per kilogram (kg) of body weight a day to start. Your doctor may increase your dose gradually every week by 5 to 10 mg per kg of body weight if needed. However, the dose is usually not more than 60 mg per kg of body weight a day. If the total dose a day is greater than 250 mg, it is usually divided into smaller doses and taken two or more times during the day.

      • Children below 10 years of age—Use and dose must be determined by your doctor.



Missed Dose


If you miss a dose of divalproex sodium, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Precautions While Using divalproex sodium


It is very important that your doctor check your progress closely while you are using divalproex sodium to see if it is working properly and to allow for a change in the dose. Blood tests may be needed to check for any unwanted effects.


Using divalproex sodium while you are pregnant (especially during first trimester) can harm your unborn baby. Use an effective form of birth control to keep from getting pregnant. If you think you have become pregnant while using the medicine, tell your doctor right away.


It is very important to take folic acid before getting pregnant and during early pregnancy to lower chances of harmful side effects to your unborn baby. Ask your doctor or pharmacist for help if you are not sure how to choose a folic acid product.


Liver problems may occur while you are using divalproex sodium. Stop using divalproex sodium and check with your doctor right away if you are having more than one of these symptoms: abdominal pain or tenderness; clay-colored stools; dark urine; decreased appetite; fever; headache; itching; loss of appetite; nausea and vomiting; skin rash; swelling of the feet or lower legs; unusual tiredness or weakness; or yellow eyes or skin.


Pancreatitis may occur while you are using divalproex sodium. Tell your doctor right away if you have sudden and severe stomach pain, chills, constipation, nausea, vomiting, fever, or lightheadedness.


Check with your doctor right away if you are having unusual drowsiness, dullness, tiredness, weakness or feelings of sluggishness, changes in mental status, or vomiting. These may be symptoms of a serious condition called hyperammonemic encephalopathy.


Divalproex sodium may cause some people to become dizzy, lightheaded, drowsy, or less alert than they are normally. Make sure you know how you react to divalproex sodium before you drive, use machines, or do anything else that could be dangerous if you are dizzy or not alert.


Do not stop taking divalproex sodium without first checking with your doctor. Your doctor may want you to gradually reduce the amount you are using before stopping completely.


Before you have any medical tests, tell the medical doctor in charge that you are taking divalproex sodium. The results of some tests may be affected by divalproex sodium.


Check with your doctor right away if you have unusual drowsiness, dullness, tiredness, weakness, or feeling of sluggishness; confusion; low body temperature; or loss of consciousness while taking divalproex sodium.


divalproex sodium may cause serious allergic reactions that affect several parts of the body (e.g., liver or kidney). Check with your doctor right away if you have more than one of the following symptoms: fever; dark urine; headache; rash; stomach pain; swollen lymph glands in the neck, armpit, or groin; unusual tiredness; or yellow eyes or skin.


Divalproex sodium may cause some people to be agitated, irritable, or display other abnormal behaviors. It may also cause some people to have suicidal thoughts and tendencies or to become more depressed. If you notice any of these adverse effects, tell your doctor right away.


divalproex sodium will add to the effects of alcohol and other CNS depressants (medicines that make you drowsy or less alert). Some examples of CNS depressants are antihistamines or medicine for hay fever or colds; sedatives, tranquilizers, or sleeping medicine; prescription pain medicine or narcotics; barbiturates or medicine for seizures; muscle relaxants; or anesthetics, including some dental anesthetics. Check with your doctor before taking any of the above while you are taking divalproex sodium.


If you are taking the sprinkle capsules, part of the capsules may pass into your stool after your body has absorbed the medicine. This is normal and nothing to worry about.


Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.


divalproex sodium Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Black, tarry stools

  • bleeding gums

  • bloating or swelling of the face, arms, hands, lower legs, or feet

  • blood in the urine or stools

  • confusion

  • cough or hoarseness

  • crying

  • delusions

  • dementia

  • depersonalization

  • diarrhea

  • difficult or labored breathing

  • dysphoria

  • euphoria

  • fever or chills

  • general feeling of discomfort or illness

  • headache

  • joint pain

  • loss of appetite

  • lower back or side pain

  • mental depression

  • muscle aches and pains

  • nausea

  • nervousness

  • painful or difficult urination

  • paranoia

  • pinpoint red spots on the skin

  • quick to react or overreact emotionally

  • rapid weight gain

  • rapidly changing moods

  • runny nose

  • shakiness in the legs, arms, hands, or feet

  • shivering

  • shortness of breath

  • sleepiness or unusual drowsiness

  • sore throat

  • sweating

  • tightness in the chest

  • tingling of the hands or feet

  • trembling or shaking of the hands or feet

  • trouble with sleeping

  • unusual bleeding or bruising

  • unusual tiredness or weakness

  • unusual weight gain or loss

  • vomiting

  • wheezing

Less common
  • Abnormal dreams

  • absence of or decrease in body movement

  • anxiety

  • bloody nose

  • bloody or cloudy urine

  • blurred vision

  • bruising burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings

  • change in personality

  • change in walking and balance

  • changes in patterns and rhythms of speech

  • chest pain

  • chills

  • clumsiness or unsteadiness

  • cold sweats

  • constipation

  • darkened urine

  • degenerative disease of the joint

  • difficulty with moving

  • discouragement

  • dizziness

  • dizziness, faintness, or lightheadedness when getting up from a lying or sitting position suddenly

  • dry mouth

  • excessive muscle tone

  • fast, irregular, pounding, or racing heartbeat or pulse

  • fear

  • feeling of warmth or heat

  • feeling sad or empty

  • flushing or redness of the skin, especially on the face and neck

  • frequent urge to urinate

  • heavy non-menstrual vaginal bleeding

  • hyperventilation

  • increased need to urinate

  • indigestion

  • irritability

  • lack of appetite

  • lack of coordination

  • large, flat, blue, or purplish patches in the skin

  • leg cramps

  • lip smacking or puckering

  • loss of bladder control

  • loss of interest or pleasure

  • loss of strength or energy

  • multiple swollen and inflamed skin lesions

  • muscle pain or stiffness

  • muscle tension or tightness

  • normal menstrual bleeding occurring earlier, possibly lasting longer than expected

  • pains in the stomach, side, or abdomen, possibly radiating to the back

  • passing urine more often

  • pounding in the ears

  • puffing of the cheeks

  • rapid or worm-like movements of the tongue

  • rapid weight gain

  • restlessness

  • seeing, hearing, or feeling things that are not there

  • shakiness and unsteady walk

  • slurred speech

  • small red or purple spots on the skin

  • sweating

  • swollen joints

  • tiredness

  • trouble with concentrating

  • trouble with speaking

  • twitching

  • uncontrolled chewing movements

  • uncontrolled movements of the arms and legs

  • unsteadiness, trembling, or other problems with muscle control or coordination

  • vomiting of blood or material that looks like coffee grounds

  • yellow eyes or skin

Get emergency help immediately if any of the following symptoms of overdose occur:


Symptoms of overdose
  • Change in consciousness

  • fainting

  • loss of consciousness

  • slow or irregular heartbeat

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Acid or sour stomach

  • belching

  • body aches or pain

  • change in vision

  • congestion

  • continuing ringing or buzzing or other unexplained noise in the ears

  • hair loss or thinning of the hair

  • hearing loss

  • heartburn

  • impaired vision

  • lack or loss of strength

  • loss of memory

  • problems with memory

  • rash

  • seeing double

  • sleeplessness

  • tender, swollen glands in the neck

  • trouble with swallowing

  • unable to sleep

  • uncontrolled eye movements

  • voice changes

  • weight gain

  • weight loss

Less common
  • Absent, missed, or irregular menstrual periods

  • back pain

  • burning, dry, or itching eyes

  • change in taste or bad unusual or unpleasant (after) taste

  • coin-shaped lesions on the skin

  • cough producing mucus

  • cramps

  • dandruff

  • discharge or excessive tearing

  • dry skin

  • earache

  • excess air or gas in the stomach or intestines

  • eye pain

  • feeling of constant movement of self or surroundings

  • full feeling

  • heavy bleeding

  • increased appetite

  • itching of the vagina or genital area

  • itching skin

  • loss of bowel control

  • neck pain

  • oily skin

  • pain

  • pain during sexual intercourse

  • pain or tenderness around the eyes and cheekbones

  • passing gas

  • rash with flat lesions or small raised lesions on the skin

  • redness or swelling in the ear

  • redness, pain, swelling of the eye, eyelid, or inner lining of the eyelid

  • redness, swelling, or soreness of the tongue

  • sensation of spinning

  • sneezing

  • stiff neck

  • stopping of menstrual bleeding

  • thick, white vaginal discharge with no odor or with a mild odor

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: divalproex sodium side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More divalproex sodium resources


  • Divalproex sodium Side Effects (in more detail)
  • Divalproex sodium Use in Pregnancy & Breastfeeding
  • Drug Images
  • Divalproex sodium Drug Interactions
  • Divalproex sodium Support Group
  • 129 Reviews for Divalproex sodium - Add your own review/rating


  • Divalproex Sodium Monograph (AHFS DI)

  • Depakote Prescribing Information (FDA)

  • Depakote Consumer Overview

  • Depakote Delayed-Release Tablets MedFacts Consumer Leaflet (Wolters Kluwer)

  • Depakote ER Prescribing Information (FDA)

  • Depakote ER Extended-Release Tablets MedFacts Consumer Leaflet (Wolters Kluwer)



Compare divalproex sodium with other medications


  • Bipolar Disorder
  • Epilepsy
  • Hyperekplexia
  • Mania
  • Migraine Prevention

Wednesday, May 6, 2009

Cervical Cancer Medications


Drugs associated with Cervical Cancer

The following drugs and medications are in some way related to, or used in the treatment of Cervical Cancer. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Cervical Cancer





Drug List:

Saturday, May 2, 2009

Petogen-Fresenius




Petogen-Fresenius may be available in the countries listed below.


Ingredient matches for Petogen-Fresenius



Medroxyprogesterone

Medroxyprogesterone 17α-acetate (a derivative of Medroxyprogesterone) is reported as an ingredient of Petogen-Fresenius in the following countries:


  • South Africa

International Drug Name Search